Skye Bioscience, Inc.
Ticker: SKYE
| Insider | Title |
|---|---|
| Andrew J. Schwab | Director |
| Annalisa Jenkins | Director |
| Co-investors Ii Lp 5am | 10% or greater ownership |
| Deborah H. Charych | Director |
| Health Sciences Inc. Emerald | 10% or greater ownership |
| James L Heppell | Director |
| John D Diekman | 10% or greater ownership |
| Kaitlyn Arsenault | Chief Financial Officer |
| Karen L. Smith | Director |
| Keith Wayne Ward | Director |
| Kush Parmar | 10% or greater ownership |
| Margaret Dalesandro | Director |
| Partners Ii, Llc 5am | 10% or greater ownership |
| Partners Vii, Llc 5am | 10% or greater ownership |
| Paul A. Grayson | Director |
| Praveen Tyle | Director |
| Puneet S. Arora | Chief Medical Officer |
| Punit Dhillon | Chief Executive Officer, Director |
| Scott M Rocklage | 10% or greater ownership |
| Sukhwinder Singh Rai | Director |
| Tuan Tu Diep | Chief Development Officer |
| Ventures Ii Lp 5am | 10% or greater ownership |
| Ventures Vii, L.p. 5am | 10% or greater ownership |